Advancing Cell & Gene Therapy Webinar

About the workshop

Advancements in viral-vector technology have shown great potential in effectively delivering genes and sequences into cells. However, mastering precise, efficient expression to avoid host immune response is crucial to unlocking successful therapies. In this webinar, we will explore the use of viral vectors, such as lentivirus, baculovirus, and adeno-associated virus, and their successful development for gene therapy applications.

What you'll learn about

How to expedite the development of the viral-vector pipeline, including:

Synthesis, packaging, and characterization
Post-treatment confirmation
Analysis of unwanted or off-target insertions in treated samples

Elizabeth (Liz) Louie, Ph.D.

Manager, Technical Applications, Azenta Life Sciences

Dr. Liz Louie earned her Ph.D. in molecular and cellular pharmacology from Stony Brook University. She joined Azenta in 2011, overseeing gene synthesis and molecular genetics projects while supporting the Project Management team with customer-facing project design and execution. Later, she led the expansion and management of molecular biology and oligo synthesis operations at the Azenta genomics facility in Boston, MA. Currently, Dr. Louie provides consultative and project design support for researchers and investigators, focusing on genomics, transcriptomics, and proteomics solutions. Her expertise includes next generation sequencing (NGS), DNA and RNA synthesis, genotyping methods, and cell and gene editing workflows.

Advancing Cell & Gene Therapy Development with Streamlined Viral-Vector Sequencing and Production

About the workshop

What you'll learn about

About the presenter

Elizabeth (Liz) Louie, Ph.D.

Watch now